‘‘(A) A summary and evaluation of 
progress made to achieve the objectives de-
scribed in subsection (b), including the goal to 
end preventable child and maternal deaths, and 
the progress made toward achieving the goal of 
reducing life threatening morbidity and mor-
tality for at least 15,000,000 children and at 
least 600,000 women. 
‘‘(B) A description of the nature and ex-
tent of coordination among relevant Federal de-
partments and agencies on the implementation 
of the strategy. 
‘‘(C) A description of how each aspect of 
the strategy is being implemented, including— 
‘‘(i) the manner in which multi-sec-
toral approaches and concrete, high-im-
pact, 
evidence-based 
interventions 
are 
being used to address the leading causes of 
preventable child and maternal deaths; 
‘‘(ii) the degree to which the strategy 
increases assistance to and activities by the 
United States in target countries; 
‘‘(iii) the use of programs, projects, or 
activities to develop and scale-up new tech-
nologies and approaches, including those 
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS
identified by public-private partnerships 
for research and innovation, and the de-
gree to which such programs, projects, or 
activities are posed to go to scale; and 
‘‘(iv) the methods used to leverage in-
novative financing and other public and 
private resources and the progress made by 
such methods. 
‘‘(D) A description of how each program, 
project, or activity implementing the strategy is 
designed to— 
‘‘(i) reach underserved, marginalized, 
vulnerable, or impoverished populations; 
‘‘(ii) address the causes of newborn, 
infant, child, and maternal morbidity and 
mortality, including pre-term births, with 
innovative efforts and interventions; 
‘‘(iii) invest in programs, projects, or 
activities that empower women, support 
voluntarism, and provide quality, respect-
ful, evidence-based maternity care; 
‘‘(iv) improve transparency and ac-
countability at all levels and include com-
mon metrics for tracking progress in 
achieving the objectives of the strategy; 
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS
‘‘(v) ensure that high-impact, evi-
dence-based interventions are prioritized, 
including interventions promoting healthy 
pregnancies; and 
‘‘(vi) expand access to quality services 
for healthcare workers and for commu-
nities in target countries and include meas-
ures of accountability to such communities. 
‘‘(E) A comprehensive list of grants, con-
tracts, and cooperative agreements awarded to 
implement the strategy, that includes— 
‘‘(i) a description of the targets for 
coverage of interventions or services sup-
ported by such grants, contracts, or coop-
erative agreements, the baseline against 
which they are measured, and the status of 
their progress in meeting the targets; or 
‘‘(ii) in the case of exceptional cir-
cumstances where the inclusion of targets 
or baseline measurements is not reasonable 
or practicable, an explanation of how the 
impact of the grant, contract, agreement, 
or resulting program is being measured. 
‘‘(F) A description of how the Adminis-
trator has partnered with relevant partner enti-
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS
ties at the national and local levels, including as 
subgrantees. 
‘‘(G) A determination, after applying rig-
orous monitoring and evaluation methodologies, 
whether the programs, projects, or activities im-
plementing the strategy have achieved measur-
able improvements in child and maternal health 
or survival, particularly among the most vulner-
able populations, in each target country and 
overall, and the specific improvements achieved 
with respect to— 
‘‘(i) the maternal mortality ratio per 
100,000 live births and the under-5 mor-
tality ratio per 1,000 live births; 
‘‘(ii) the number of newborn, infant, 
child, and maternal deaths averted; and 
‘‘(iii) the percentage of births at-
tended by skilled health personnel. 
‘‘(H) An analysis of the gaps in the health 
workforce that must be filled in order to end 
preventable newborn, infant, child and maternal 
deaths, including an analysis of health work-
force density relating to certified health workers 
and community-based health workers. 
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS
‘‘(I) A description of the measured or esti-
mated impact on newborn, infant, child, and 
maternal survival of each ongoing program, 
project, or activity implementing the strategy. 
‘‘(J) An assessment of progress made to-
ward achieving the targets established pursuant 
to subsection (c)(2)(A). 
‘‘(K) A description of any innovative pub-
lic-private financing tools, including an analysis 
of the feasibility and potential effectiveness, 
that could be used to fund efforts to end pre-
ventable child and maternal deaths. 
‘‘(h) DEFINITIONS.—In this section: 
‘‘(1) ADMINISTRATOR.—The term ‘Adminis-
trator’ means the Administrator of the United 
States Agency for International Development. 
‘‘(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘appropriate congressional com-
mittees’ means— 
‘‘(A) the Committee on Foreign Relations 
and the Committee on Appropriations of the 
Senate; and 
‘‘(B) the Committee on Foreign Affairs 
and the Committee on Appropriations of the 
House of Representatives. 
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS
‘‘(3) RELEVANT FEDERAL DEPARTMENTS AND 
AGENCIES.—The term ‘relevant Federal departments 
and agencies’ includes each of the following: 
‘‘(A) The Department of State. 
‘‘(B) The United States Agency for Inter-
national Development, including the President’s 
Malaria Initiative. 
‘‘(C) The Department of Health and 
Human Services. 
‘‘(D) The Department of the Treasury. 
‘‘(E) The Department of Defense. 
‘‘(F) The Centers for Disease Control and 
Prevention. 
‘‘(G) The National Institutes of Health. 
‘‘(H) The Millennium Challenge Corpora-
tion. 
‘‘(I) The Peace Corps. 
‘‘(J) The Office of the Global AIDS Coor-
dinator. 
‘‘(K) Any other Federal department or 
agency determined by the President to be rel-
evant to carry out the purposes of this section. 
‘‘(4) 
RELEVANT
PARTNER
ENTITIES.—The 
term ‘relevant partner entities’ means each of the 
following: 
VerDate Sep 11 2014 
02:34 Oct 13, 2017
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H4022.IH
H4022
dlhill on DSK3GLQ082PROD with BILLS